JP2019052182A5 - - Google Patents

Download PDF

Info

Publication number
JP2019052182A5
JP2019052182A5 JP2018236137A JP2018236137A JP2019052182A5 JP 2019052182 A5 JP2019052182 A5 JP 2019052182A5 JP 2018236137 A JP2018236137 A JP 2018236137A JP 2018236137 A JP2018236137 A JP 2018236137A JP 2019052182 A5 JP2019052182 A5 JP 2019052182A5
Authority
JP
Japan
Prior art keywords
subject
cell sample
pharmaceutical formulation
composition
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018236137A
Other languages
English (en)
Japanese (ja)
Other versions
JP6900358B2 (ja
JP2019052182A (ja
Filing date
Publication date
Priority claimed from US14/577,978 external-priority patent/US20150174166A1/en
Priority claimed from JP2016558732A external-priority patent/JP6471302B2/ja
Application filed filed Critical
Publication of JP2019052182A publication Critical patent/JP2019052182A/ja
Publication of JP2019052182A5 publication Critical patent/JP2019052182A5/ja
Application granted granted Critical
Publication of JP6900358B2 publication Critical patent/JP6900358B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018236137A 2014-03-24 2018-12-18 細胞復元のための無細胞組成物及び同組成物の作成及び使用方法 Active JP6900358B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201461969694P 2014-03-24 2014-03-24
US61/969,694 2014-03-24
US14/577,978 US20150174166A1 (en) 2013-12-20 2014-12-19 Compositions for Cellular Restoration and Methods of Making and Using Same
PCT/US2014/071667 WO2015095794A1 (en) 2013-12-20 2014-12-19 Compositions for cellular restoration and methods of making and using same
USPCT/US2014/071667 2014-12-19
US14/577,978 2014-12-19
JP2016558732A JP6471302B2 (ja) 2014-03-24 2015-03-24 細胞復元のための無細胞組成物及び同組成物の作成及び使用方法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2016558732A Division JP6471302B2 (ja) 2014-03-24 2015-03-24 細胞復元のための無細胞組成物及び同組成物の作成及び使用方法

Publications (3)

Publication Number Publication Date
JP2019052182A JP2019052182A (ja) 2019-04-04
JP2019052182A5 true JP2019052182A5 (cg-RX-API-DMAC7.html) 2019-05-16
JP6900358B2 JP6900358B2 (ja) 2021-07-07

Family

ID=54196315

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016558732A Active JP6471302B2 (ja) 2014-03-24 2015-03-24 細胞復元のための無細胞組成物及び同組成物の作成及び使用方法
JP2018236137A Active JP6900358B2 (ja) 2014-03-24 2018-12-18 細胞復元のための無細胞組成物及び同組成物の作成及び使用方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2016558732A Active JP6471302B2 (ja) 2014-03-24 2015-03-24 細胞復元のための無細胞組成物及び同組成物の作成及び使用方法

Country Status (4)

Country Link
EP (2) EP3122333A4 (cg-RX-API-DMAC7.html)
JP (2) JP6471302B2 (cg-RX-API-DMAC7.html)
CR (1) CR20160495A (cg-RX-API-DMAC7.html)
WO (1) WO2015148534A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11286463B2 (en) 2012-03-08 2022-03-29 Advanced ReGen Medical Technologies, LLC Reprogramming of aged adult stem cells
US20150174166A1 (en) 2013-12-20 2015-06-25 Advanced ReGen Medical Technologies, LLC Compositions for Cellular Restoration and Methods of Making and Using Same
US10772911B2 (en) 2013-12-20 2020-09-15 Advanced ReGen Medical Technologies, LLC Cell free compositions for cellular restoration and methods of making and using same
CN109475645A (zh) 2016-04-29 2019-03-15 先进瑞金医疗技术有限公司 微rna组合物及其制备和使用方法
EP3740576A4 (en) 2018-01-18 2021-10-20 Advanced Regen Medical Technologies, LLC THERAPEUTIC COMPOSITIONS AND THEIR PREPARATION AND USE METHODS

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005121369A2 (en) * 2004-06-02 2005-12-22 Sourcepharm, Inc. Rna-containing microvesicles and methods therefor
CN102802519B (zh) * 2009-06-25 2014-12-31 株式会社日立医疗器械 医用图像摄影装置
EP2363136A1 (en) * 2010-03-02 2011-09-07 Fresenius Medical Care Deutschland GmbH Microvesicles (MVs) derived from adult stem cells for use in the therapeutic treatment of a tumor disease
US20120093885A1 (en) * 2010-10-18 2012-04-19 Northwestern University Therapeutic vesicles
US8747915B1 (en) 2011-09-14 2014-06-10 Vincent C. Giampapa Dietary supplement system for multifunctional anti-aging management and method of use
WO2013066368A1 (en) * 2011-10-03 2013-05-10 The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services Use of mirna 126 to produce hematopoietic stem cells
US9427450B2 (en) * 2012-01-31 2016-08-30 Xon Cells, Inc. Therapeutic immune modulation by stem cell secreted exosomes
US9295696B2 (en) * 2012-06-08 2016-03-29 University of Pittsburgh—of the Commonwealth System of Higher Education Compositions and methods for restoring or rejuvenating stem/progenitor cell function
EP3563859B1 (en) 2012-08-13 2021-10-13 Cedars-Sinai Medical Center Cardiosphere-derived exosomes for tissue regeneration

Similar Documents

Publication Publication Date Title
Shi et al. Angiotensin II induces vascular endothelial growth factor synthesis in mesenchymal stem cells
EP4289951A3 (en) Circular rna compositions and methods
JP2019515908A5 (cg-RX-API-DMAC7.html)
US12048687B2 (en) Methods of recruiting SDF-producing macrophages
Li et al. Biological characteristics of tissue engineered-nerve grafts enhancing peripheral nerve regeneration
JP2016505623A5 (cg-RX-API-DMAC7.html)
Song et al. Aged human multipotent mesenchymal stromal cells can be rejuvenated by neuron-derived neurotrophic factor and improve heart function after injury
RU2015138483A (ru) Способы получения из опухоли обогащенных популяций реактивных в отношении опухоли т-клеток
MX352647B (es) Metodo para temporizar una colonoscopia en donde se administra una composicion de picosulfato.
TW201709915A (zh) 用於治療肝臟疾病的間葉幹細胞
BR112022026550A2 (pt) Composição de compostos que modulam o metabolismo celular e métodos de uso
JP2021523883A5 (cg-RX-API-DMAC7.html)
JP7784401B2 (ja) 幹細胞の治療特性を改善するための方法
US11471476B2 (en) Microrna and uses thereof in prevention and/or treatment of fibroplasia medical sign and/or syndrome
JP2016510808A5 (cg-RX-API-DMAC7.html)
CN104530209A (zh) 中华大蟾蜍抗菌肽bg-cath37、bg-cath(5-37)及其编码基因和应用
Makedonova et al. Studying clinical and pathomorphological changes in gingival tissues when applying platelet-rich autoplasma regenerative method
JP2008540536A5 (cg-RX-API-DMAC7.html)
CN118384269A (zh) 阿托伐他汀钙在制备增强树突状细胞疫苗抗肿瘤制剂中的应用
JP2016502527A5 (cg-RX-API-DMAC7.html)
Bakova et al. Application Of Bioprinting In Contemporary Medicine
JP2025505589A5 (cg-RX-API-DMAC7.html)
Iryshkin et al. Etiology, pathogenesis and morphology of biliary atresia
JP2016514142A5 (cg-RX-API-DMAC7.html)
Sahoo et al. Study of effect of various treatments in clinically diagnosed patients of carpal tunnel syndrome